PACED Act
Latest action · Jun 28, 2019 Placed on Senate Legislative Calendar under General Orders. Calendar No. 129.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 12, 2019
- Passed SenateNot reached
- Passed HouseNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Preserving Access to Cost Effective Drugs Act or the PACED Act
This bill prohibits patent owners from asserting tribal sovereign immunity as a defense in certain proceedings before the U.S. Patent and Trademark Office, including patent validity challenge proceedings before the Patent Trial and Appeal Board (PTAB). The prohibition also applies to court actions and proceedings before the International Trade Commission.
Sovereign immunity for foreign states shall apply in the PTAB as it applies in federal court. The abrogation of sovereign immunity shall not apply to states or institutions of higher education (i.e., public state universities and institutions).
Cosponsors 2
Members who signed on, in the order they did. All signed on Feb 12, 2019.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-IA | Joni Ernst | Original | Feb 12, 2019 |
| R-PA | Patrick J. Toomey | Original | Feb 12, 2019 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| Senate | Judiciary Committee | Referred Feb 12, 2019Markup Jun 27, 2019Reported Jun 28, 2019 |
Actions 5
Everything that happened, newest first.
- Jun 28, 2019Committee on the Judiciary. Reported by Senator Graham with an amendment in the nature of a substitute. Without written report.
- Jun 28, 2019Placed on Senate Legislative Calendar under General Orders. Calendar No. 129.
- Jun 27, 2019Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
- Feb 12, 2019Introduced in Senate
- Feb 12, 2019Read twice and referred to the Committee on the Judiciary.
In the Congressional Record 1
Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.
| Where | In the Record | Members | Date |
|---|---|---|---|
| Senate | Debate and remarks S4753 | Joni Ernst R-IA | Jul 10, 2019 |
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Congressional Budget Office cost estimate
- Jul 19, 2019S. 440, PACED ActAs reported by the Senate Committee on the Judiciary on June 28, 2019
CRS reports 1
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 1
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| R46741 | Drug Pricing and Intellectual Property: The Legislative Landscape for the 117th Congress | Report | Mar 31, 2021 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 2514 | PACED Act | Reintroduction of | Mar 7, 2018 |
Titles 5
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- A bill to amend title 35, United States Code, to provide that a patent owner may not assert sovereign immunity as a defense in certain actions before the United States Patent and Trademark Office, and for other purposes.
- Short Title(s) as Introduced
- PACED Act
- Preserving Access to Cost Effective Drugs Act
- Short Title(s) as Reported to Senate
- PACED Act
- Preserving Access to Cost Effective Drugs Act
Subjects
Assigned by the Library of Congress. Policy area: Commerce.
Text 2
Each version as it was printed, newest first.
- Jun 28, 2019Reported to Senate
- Feb 12, 2019Introduced in Senate
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.